Mounjaro

Mounjaro is a prescription‑only medicine and must be used under the supervision of a qualified healthcare professional. It is not suitable for people with a history of severe allergic reactions to its ingredients. Possible side effects include nausea, vomiting, diarrhoea and decreased appetite. Please let us know if you have any underlying medical conditions. Always follow the prescribed dosing instructions.

Before using Mounjaro, ensure you have been assessed and prescribed the correct strength. Store the pens in the refrigerator and allow them to reach room temperature before injecting. Ensure your skin is clean, then pinch the skin, and inject at a 90‑degree angle into the stomach, thigh or upper arm. Rotate injection sites and never reuse a pen needle. Dispose of used pen needles in a sharps bin. If you miss a dose, follow the instructions provided by our pharmacist. If you miss a dose, take it as soon as possible that day, or follow the instructions provided by our pharmacist. Store unused pens in the refrigerator, away from direct light and heat, and once in use, pens can be kept at room temperature for up to 4 weeks. Contact our pharmacist or your doctor if you experience any adverse reactions or have questions about your medication, and always follow their specific instructions and the medication guide provided.

Active Ingredient

Tirzepatide: A dual GLP-1 and GIP receptor agonist used to improve blood sugar control in adults with type 2 diabetes.

Inactive Ingredients

• Sodium Chloride: Used to maintain the appropriate salt balance in the solution.
• Sodium Phosphate Dibasic: Acts as a buffering agent to maintain the pH of the solution.
• Sodium Phosphate Monobasic: Another buffering agent to stabilise the pH.
• Mannitol: A sugar alcohol that helps stabilise the solution.
• Hydrochloric Acid (pH adjustment): Used to adjust the acidity of the solution.
• Sodium Hydroxide (pH adjustment): Used to balance the solution’s pH.
• Water for Injection: Sterile water used to dissolve the active and inactive ingredients.

These ingredients combine to create a stable, effective injectable solution for managing type 2 diabetes. Always refer to the official medication guide for the most detailed and up‑to‑date information.

Possible Side Effects of Mounjaro

Common Side Effects

• Nausea
• Diarrhoea
• Decreased appetite
• Vomiting
• Constipation
• Indigestion

Less Common Side Effects

• Abdominal pain
• Fatigue
• Injection site reactions (such as redness, swelling or itching)
• Gastro‑oesophageal reflux disease (GERD)

Serious Side Effects

• Severe allergic reactions (rash, swelling, severe dizziness, difficulty breathing)
• Pancreatitis — symptoms include severe stomach or abdominal pain, persistent nausea or vomiting
• Kidney problems (changes in urination or reduced urine output)
• Gallbladder problems such as gallstones or cholecystitis (severe stomach pain, yellowing of skin or eyes)
• Severe hypoglycaemia, especially when combined with other diabetes medication

Note: This is not a complete list of side effects. If you experience any unusual symptoms, seek medical advice promptly. Always follow the guidance provided by your healthcare professional.

Frequently Asked Questions

What is Mounjaro used for?

Mounjaro is used for weight-loss support and to improve blood sugar control. It is commonly prescribed privately for obesity management and metabolic conditions.

How quickly does Mounjaro work?

Most people begin noticing reduced appetite within the first few weeks. Weight loss typically increases as the dose is gradually escalated.

Do I need a prescription?

Yes. Mounjaro can only be supplied after our pharmacists have reviewed your medical questionnaire and confirmed that treatment is suitable for you.

Can Mounjaro be delivered?

Yes — we offer next‑day, temperature‑controlled delivery across the UK to ensure the medication remains within the recommended cold‑chain range.

What strengths of Mounjaro are available?

We supply 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg pens as part of the standard dose‑escalation schedule.